Neuren Pharmaceuticals Ltd
ASX:NEU
Neuren Pharmaceuticals Ltd
Operating Income
Neuren Pharmaceuticals Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Operating Income
AU$204.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Operating Income
-AU$165.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Operating Income
-AU$18.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-28%
|
|
Probiotec Ltd
ASX:PBP
|
Operating Income
AU$20m
|
CAGR 3-Years
31%
|
CAGR 5-Years
24%
|
CAGR 10-Years
30%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Operating Income
-AU$26.4m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Arovella Therapeutics Ltd
ASX:ALA
|
Operating Income
-AU$9.7m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
See Also
What is Neuren Pharmaceuticals Ltd's Operating Income?
Operating Income
204.9m
AUD
Based on the financial report for Dec 31, 2023, Neuren Pharmaceuticals Ltd's Operating Income amounts to 204.9m AUD.
What is Neuren Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
102%